Interleukin-2 Inhibits Secretin-Induced Bile Secretion in Cholangiocytes

  • Ko, Yoo-Seung (School of Life Sciences, Immune Synapse Research Center and Cell Dynamics Research Center, Gwangju Institute of Science and Technology) ;
  • Hwang, Seock-Yeon (College of Applied Science and Industry, Daejeon University) ;
  • Park, Jae-Seung (Department of Clinical Pathology, Sohae University)
  • Received : 2012.10.17
  • Accepted : 2013.06.19
  • Published : 2013.06.29

Abstract

Cholestatic liver is associated with hepatic inflammation and elevated proinflammatory cytokines. Recent studies indicate that certain cytokines can modulate bile secretion. In the present study, we have examined the role of interleukin (IL-2) on the bile secretion by a combination of study models. To examine the relevance of IL-2 on bile secretion, the expression of IL-2 and IL-2 receptor (IL-2R) of isolated normal and bile duct ligated (BDL) rats cholangiocytes was first measured by RT-PCR. In BDL rats, the expression of IL-2 and IL-2R was significantly increased compared with normal rats. To study the effect of IL-2 on bile secretion, bile flow was measured in normal and BDL rats. At the level of cholangiocytes, secretory responses of isolated bile duct unit (IBDU)s were quantified by videomicroscopy. The administrations of IL-2 had no significant effect on basal bile secretion in normal and BDL rats. There was no significant effect of IL-2 on basal bile ductular secretion as evidenced by no significant difference in luminal area of the IBDUs perfusedwith 100 pM of IL-2 from those of albumin carrier control. However, the secretin-stimulated bile ductular secretion was significantly (P < 0.01) inhibited by $34{\pm}4%$ (normal, n = 12), $21{\pm}5.3%$ (BDL 2 wk, n = 12) and $15{\pm}5.2%$ (BDL 4 wk, n = 12) with the co-administration of IL-2. As with other cytokines, physiologically relevant concentration of IL-2 can significantly inhibit secretin-stimulated bile ductular secretion. These findings support the important roles of cytokines in modulating bile secretion and may contribute to the cholestasis seen in cholestatic liver diseases.

Keywords

References

  1. Alpini G, Lenzi R, Zhai WR, Slott PA, Liu MH, Sarkozi L, Tavoloni N. Bile secretory function of intrahepatic biliary epithelium in the rat. Am J Physiol Gastrointest Liver Physiol. 1989. 257: G124-G133. https://doi.org/10.1152/ajpgi.1989.257.1.G124
  2. Beadling C, Johnson KW, Smith KA. Isolation of interleukin 2-induced immediate-early genes. Proc Natl Acad Sci U S A. 1993. 90: 2719-2723. https://doi.org/10.1073/pnas.90.7.2719
  3. Braunstein GM, Roman RM, Clancy JP, Kudlow BA, Taylor AL, Shylonsky VG, Jovov B, Peter K, Jilling T, Ismailov II, Benos DJ, Schwiebert LM, Fitz JG, Schwiebert EM. Cystic fibrosis transmembrane conductance regulator facilitates ATP release by stimulating a separate ATP release channel for autocrine control of cell volume regulation. J Biol Chem. 2001. 276: 6621-6630. https://doi.org/10.1074/jbc.M005893200
  4. Cantrell DA, Smith KA. The interleukin-2 T-cell system: a new cell growth model. Science. 1984. 224: 1312-1316. https://doi.org/10.1126/science.6427923
  5. Cho WK, Mennone A, Boyer JL. Isolation of functional polarized bile duct units from mouse liver. Am J Physiol Gastrointest Liver Physiol. 2001. 280: G241-G246. https://doi.org/10.1152/ajpgi.2001.280.2.G241
  6. Cho WK, Boyer JL. Vasoactive intestinal polypeptide is a potent regulator of bile secretion from rat cholangiocytes. Gastroenterology. 1999. 117: 420-428. https://doi.org/10.1053/gast.1999.0029900420
  7. Chow BK, Cheung KH, Tsang EM, Leung MC, Lee SM, Wong PY. "Secretin controls anion secretion in the rat epididymis in an autocrine/paracrine fashion". Biol Reprod. 2004. 70: 1594-1599. https://doi.org/10.1095/biolreprod.103.024257
  8. Clarke LL, Grubb BR, Gabriel SE, Smithies O, Koller BH, Boucher RC. Defective epithelial chloride transport in a gene-targeted mouse model of cystic fibrosis. Science. 1992. 257: 1125-1128. https://doi.org/10.1126/science.257.5073.1125
  9. Cohn JA, Strong TV, Picciotto MR, Nairn AC, Collins FS, Fitz JG. Localization of the cystic fibrosis transmembrane conductance regulator in human bile duct epithelial cells. Gastroenterology. 1993. 105: 1857-1864. https://doi.org/10.1016/0016-5085(93)91085-V
  10. Dumoulin FL, Bach A, Leifeld L, El-Bakri M, Fischer HP, Sauerbruch T, Spengler U. Semiquantitative analysis of intrahepatic cytokine mRNAs in chronic hepatitis C. J Infect Dis. 1997. 175: 681-685. https://doi.org/10.1093/infdis/175.3.681
  11. Feranchak AP, Fitz JG, Roman RM. Volume-sensitive purinergic signaling in human hepatocytes. J Hepatol. 2000. 33: 174-182. https://doi.org/10.1016/S0168-8278(00)80357-8
  12. Gabriel SE, Brigman KN, Koller BH, Boucher RC, Stutts MJ. Cystic fibrosis heterozygote resistance to cholera toxin in the cystic fibrosis mouse model. Science. 1994. 266: 107-109. https://doi.org/10.1126/science.7524148
  13. Gilman AG. "G proteins: transducers of receptor-generated signals". Annu Rev Biochem. 1987. 56: 615-649. https://doi.org/10.1146/annurev.bi.56.070187.003151
  14. Gray MA, Plant S, and Argent BE. cAMP-regulated whole cell chloride currents in pancreatic duct cells. Am J Physiol Cell Physiol. 1993. 264: C591-C602. https://doi.org/10.1152/ajpcell.1993.264.3.C591
  15. Green RM, Whiting JF, Rosenbluth AB, Beier D, Gollan JL. Interleukin-6 inhibits hepatocyte taurocholate uptake and sodium-potassium-adenosinetriphosphatase activity. Am J Physiol Gastrointest Liver Physiol. 1994. 267: G1094-G1100. https://doi.org/10.1152/ajpgi.1994.267.6.G1094
  16. Krams SM, Ascher NL, Martinez OM. New immunologic insights into the requirement for specific antigen stimulation is clear, be- mechanisms of allograft rejection. Gastroenterol Clin North Am. 1993. 22: 381-400.
  17. LeRoy EC, Trojanowska MI, Smith EA. Cytokines and human fibrosis. Eur Cytokine Netw. 1990. 1: 215-219.
  18. Marbet UA, Shefer S, Leevy CM. Studies of the influence of immunological and serological factors from patients with cholestasis due to alcoholic or viral hepatitis on biliary function in the rat. Eur J Clin Invest. 1984. 14: 346-353. https://doi.org/10.1111/j.1365-2362.1984.tb01194.x
  19. Marinelli RA, Pham L, Agre P, LaRusso NF. "Secretin promotes osmotic water transport in rat cholangiocytes by increasing aquaporin-1 water channels in plasma membrane. Evidence for a secretin-induced vesicular translocation of aquaporin-1". J Biol Chem. 1997. 272: 12984-12988. https://doi.org/10.1074/jbc.272.20.12984
  20. Mcgill JM, Basavappa S, Gettys TW, Fitz JG. Secretin activates Cl2 channels in bile duct epithelial cells through a cAMP-dependent mechanism. Am J Physiol Gastrointest Liver Physiol. 1994. 266: G731-G736. https://doi.org/10.1152/ajpgi.1994.266.4.G731
  21. Mcgill JM, Yen MS, Cummings OW, Alpini G, Lesage G, Pollok KE, Miller B, Engle SK, Ann P, Stansfield AP. Interleukin-5 inhibition of biliary cell chloride currents and bile flow. Am J Physiol Gastrointest Liver Physiol. 2001. 280: G738-G745. https://doi.org/10.1152/ajpgi.2001.280.4.G738
  22. Mennone A, Alvaro D, Cho W, Boyer JL. Isolation of small polarized bile duct units. Proc Natl Acad Sci USA. 1995. 92: 6527-6531. https://doi.org/10.1073/pnas.92.14.6527
  23. Moon JJ, Rubio ED, Martino A, Krumm A, Nelson BH. "A permissive role for phosphatidylinositol 3-kinase in the Stat5-mediated expression of cyclin D2 by the interleukin-2 receptor". J Biol Chem. 2004. 279: 5520-5527. https://doi.org/10.1074/jbc.M308998200
  24. Park JS, Choi YJ, Siegrist VJ, Ko YS, Cho WK. Permissive role of calcium on regulatory volume decrease in freshly isolated mouse cholangiocytes. Pflugers Arch. 2007. 455: 261-271. https://doi.org/10.1007/s00424-007-0274-7
  25. Reynoso-Paz S, Coppel RL, Mackay IR, Bass NM, Ansari AA, Gershwin ME. The immunobiology of bile and biliary epithelium. Hepatology. 1999. 30: 351-357.
  26. Riordan JR, Rommens JM, Kerem BS, Alon N, Rozmahel R, Grzelczak Z, Zielenski J, Lok S, Plavsic N, Chou JL, Drumm ML, Iannuzzi MC, Collins FS, Tsui LC. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science. 1989. 245: 1066-1073. https://doi.org/10.1126/science.2475911
  27. Roberts SK, Ludwig J, LaRusso NF. The pathobiology of biliary epithelia. Gastroenterology. 1997. 112: 269-279. https://doi.org/10.1016/S0016-5085(97)70244-0
  28. Stern JB, Smith KA. Interleukin-2 induction of T-cell G1 progression and c-myb expression. Science. 1986. 233: 203-206. https://doi.org/10.1126/science.3523754
  29. Trauner M, Meier PJ, Boyer JL. Molecular pathogenesis of cholestasis. N Engl J Med. 1998. 339: 1217-1227. https://doi.org/10.1056/NEJM199810223391707
  30. Ueno Y, Alpini G, Yahagi K, Kanno N, Moritoki Y, Fukushima K, Glaser S, LeSage G, Shimosegawa T. Evaluation of differential gene expression by microarray analysis in small and large cholangiocytes isolated from normal mice. Liver Int. 2003. 23: 449-459. https://doi.org/10.1111/j.1478-3231.2003.00876.x
  31. Whiting JF, Green RM, Rosenbluth AB, Gollan JL. Tumor necrosis factor-alpha decreases hepatocyte bile salt uptake and mediates endotoxin-induced cholestasis. Hepatology. 1995. 22: 1273-1278.
  32. Williams FH, Thiele DL. The role of major histocompatibility complex and non-major histocompatibility complex encoded antigens in generation of bile duct lesions during hepatic graft-vs.-host responses mediated by helper or cytotoxic T cells. Hepatology. 1994. 19: 980-988. https://doi.org/10.1002/hep.1840190425